Dermatology Section

Board 2019-2022


Charlotte Mortz - EAACI Dermatology Section Chair

Section Chair
Charlotte Mortz

Knut Brockow

Past Chair
Knut Brockow

Section Secretary
Barbara Ballmer-Weber

Board members
Maria Bova
Jose Luis Garcia-Abujeta
Margarida Goncalo
Elena Petkova
Patrizia Bonadonna

JM Representative
Daniela Carvalho


Interview with Charlotte Mortz, Odense Hospital University, and Knut Brockow, Munich Technical University


Charlotte Mortz and Knut Brockow discuss the importance and
prevalence of skin allergy

“Between 20-30% of the population has had skin allergy at
some point in their lives (...) A disease like atopic dermatitis
affects 20% of all children at some point in their childhood

June 2019



Peter Schmid-Grendelmeier discusses the biggest challenges
in allergic skin diseases and highlights European priorities in
the field

“"In the field of allergic skin diseases (there is) an increase of
atopic dermatitis, which is a global problem, (...) and a rapid
increase in some contact allergens that cause contact

June 2019


Last updated 17 November 2021
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback